Inventor
TRIPATHY RABINDRANATH
US23 patents
⚠️ This page may combine multiple inventors who share the name “TRIPATHY RABINDRANATH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEPHALON INC
11 patentsUS6455525B1Sep 24, 2002
Heterocyclic substituted pyrazolones
CEPHALON INC63 citations96
US6127401AOct 3, 2000
Bridged indenopyrrolocarbazoles
CEPHALON INC49 citations96
US5498616AMar 12, 1996
Cysteine protease and serine protease inhibitors
CEPHALON INC79 citations96
US7074793B2Jul 11, 2006
Cyclic substituted fused pyrrolocarbazoles and isoindolones
CEPHALON INC60 citations95
US6919367B2Jul 19, 2005
Substituted thioacetamides
CEPHALON INC24 citations92
US6359130B1Mar 19, 2002
Bridged indenopyrrolocarbazoles
CEPHALON INC48 citations92
US5658906AAug 19, 1997
Cysteine protease and serine protease inhibitors
CEPHALON INC9 citations73
US6841567B1Jan 11, 2005
Cyclic substituted fused pyrrolocarbazoles and isoindolones
CEPHALON INC7 citations72
US6831075B2Dec 14, 2004
Heterocyclic substituted pyrazolones
CEPHALON INC4 citations63
US7288650B2Oct 30, 2007
Cyclic substituted fused pyrrolocarbazoles and isoindolones
CEPHALON INC2 citations61
US7314875B2Jan 1, 2008
Tricyclic aromatic and bis-phenyl sulfinyl derivatives
CEPHALON INC3 citations59
IGNYTA INC
5 patentsUS9522902B2Dec 20, 2016
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC4 citations83
US9120778B2Sep 1, 2015
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC5 citations83
US9029538B2May 12, 2015
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC8 citations83
US10017496B2Jul 10, 2018
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC0 citations51
US9745283B2Aug 29, 2017
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC0 citations51